| Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression (NCT06331572) | First Affiliated Hospital of Chongqing Medical University | 2021-08-01 |
| Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals (NCT06129578) | Sergio Montserrat de la Paz | 2021-01-01 |
| Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome (NCT05255718) | Montana State University | 2019-04-27 |
| Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care (NCT03882580) | Groupe Hospitalier Pitie-Salpetriere | 2019-03-01 |
| Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products (NCT02650674) | Mondelēz International, Inc. | 2015-10-01 |
| Air Pollution and Cardiovascular Disease (NCT02573103) | WeiHuang | 2014-11-01 |
| Evaluation of Arginine in Periodontal and Cardiovascular Disease (NCT03873948) | University of Messina | 2014-01-06 |
| Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) (NCT01911091) | AdventHealth Translational Research Institute | 2013-07-01 |
| A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients (NCT01337141) | Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders | 2011-05-01 |
| A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan (NCT01738061) | Asia University | 2010-01-01 |
| The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease (NCT02059993) | Chinese Pulmonary Vascular Disease Research Group | 2009-01-01 |
| Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (NCT00707746) | Kastle Therapeutics, LLC | 2008-10-01 |
| An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia (NCT00694109) | Kastle Therapeutics, LLC | 2008-04-01 |
| Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (NCT00607373) | Kastle Therapeutics, LLC | 2007-07-01 |
| Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia (NCT00477594) | Kastle Therapeutics, LLC | 2007-05-01 |
| Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration (NCT00362180) | Kastle Therapeutics, LLC | 2006-07-01 |
| A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) (NCT00546052) | Organon and Co | 2005-09-01 |